NCT02995239View on ClinicalTrials.gov

A Study to Compare the Pharmacokinetic Characteristics of CJ-12420

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Erosive Esophagitis
Interventions
DRUG

CJ-12420 formulation 2

CJ-12420 formulation 2

DRUG

CJ-12420 formulation 1

CJ-12420 formulation 1

Trial Locations (1)

Unknown

Chonbuk National University Hospital, Jeonju

Sponsors
All Listed Sponsors
lead

HK inno.N Corporation

INDUSTRY